Journal article
Intracardiac Echocardiography to Guide Watchman FLX Implantation
- Abstract:
- Intracardiac echocardiography (ICE) is increasingly used to guide left atrial appendage closure (LAAC). Objectives: The aim of this study was to investigate the efficacy and safety of ICE-guided LAAC with the Watchman FLX device. The ICE LAA (I Can See Left Atrial Appendage) study was a prospective, multicenter study with independent adjudication of echocardiographic data by a core laboratory and clinical events by a clinical events committee. Patients with atrial fibrillation with CHADS-VASc scores ≥2 and clinical indications for LAAC were eligible. Preplanning with either cardiac computed tomography or transesophageal echocardiography (TEE) within 7 days prior to LAAC was mandatory. Intraprocedural ICE was carried out from the left atrium. The primary outcome was the rate of significant peridevice leaks (>5 mm) at 45-day TEE. A total of 100 patients were enrolled. The mean age was 76 ± 8 years, the mean CHADS-VASc score was 4.0 ± 1.5, and the mean HAS-BLED score was 2.5 ± 0.9. The incidence of the primary outcome of significant peridevice leak (>5 mm) was 0%; all patients evaluated by TEE at 45 days had effective LAAC. All patients received Watchman FLX devices, and technical success was 100%. The number of devices per case was 1.0 ± 0.1. ICE successfully guided the assessment of device release criteria, including device compression (19.2% ± 7.1%; recommended range: 10%-30%). No subject required conversion to TEE. Procedural complications were 4 access-site bleeds. There was no stroke, transient ischemic attack, systemic embolization, pericardial effusion, device embolization, or device-related thrombus during the procedure or 45-day follow-up. ICE can be used to successfully guide LAAC with the Watchman FLX, with excellent procedural success, a high rate of effective LAAC, and minimal periprocedural complications. (I Can See Left Atrial Appendage [ICELAA] Clinical Study; NCT04196335
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Version of record, jpeg, 910.6KB, Terms of use)
-
- Publisher copy:
- 10.1016/j.jcin.2022.10.024
- Publication website:
- https://ddd.uab.cat/pub/artpub/2023/302816/302816.pdf
Authors
+ Boston Scientific Corporation
More from this funder
- Funder identifier:
- 10.13039/100008497
- Grant:
- NCT04196335
- Publisher:
- Elsevier
- Journal:
- JACC: Cardiovascular Interventions More from this journal
- Volume:
- 16
- Issue:
- 6
- Pages:
- 643-651
- Publication date:
- 2023-02-08
- DOI:
- EISSN:
-
1876-7605
- ISSN:
-
1936-8798
- Language:
-
English
- Keywords:
- Pubs id:
-
1544444
- Local pid:
-
pubs:1544444
- Source identifiers:
-
W4319460023
- Deposit date:
-
2026-05-17
- ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.
Terms of use
- Copyright date:
- 2023
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record